+499.5%
MRNA vs ETR
+23.8%
+475.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ETR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.8% | -2.2% |
| 7D | +5.5% | +1.4% | +4.0% | +5.4% |
| 30D | +158.7% | +1.0% | +157.7% | +158.3% |
| 3M | +182.1% | -1.3% | +183.4% | +181.8% |
| 6M | +151.8% | +1.9% | +149.9% | +149.9% |
| YTD | +393.6% | +18.2% | +375.4% | +340.2% |
| 1Y | +499.5% | +24.7% | +474.8% | +464.6% |
| All | +499.5% | +23.8% | +475.6% | +464.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ETR.
Daily Out/Under-Performance
Portfolio return minus ETR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ETR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ETR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling